1. NOX enzymes as drug targets

   • Karl-Heinz Krause
   • David Lambeth
   • Martin Krönke

   Multi-author review Open access 15 May 2012 Pages: 2279 - 2282

2. Strategies for identifying synthetic peptides to act as inhibitors of NADPH oxidases, or “All that you did and did not want to know about Nox inhibitory peptides”

   • Iris Dahan
   • Edgar Pick

   Multi-author review 06 May 2012 Pages: 2283 - 2305

   

3. Towards specific NADPH oxidase inhibition by small synthetic peptides

   • Jamel El-Benna
   • Pham My-Chan Dang
   • Axel Périanin

   Multi-author review 06 May 2012 Pages: 2307 - 2314

   

4. NADPH oxidase inhibitors: a decade of discovery from Nox2ds to HTS

   • Eugenia Cifuentes-Pagano
   • Gabor Csanyi
   • Patrick J. Pagano

   Multi-author review 15 May 2012 Pages: 2315 - 2325

   

5. The NOX toolbox: validating the role of NADPH oxidases in physiology and disease

   • Sebastian Altenhöfer
   • Pamela W. M. Kleikers
   • Harald H. H. W. Schmidt

   Multi-author review Open access 31 May 2012 Pages: 2327 - 2343

   

6. NADPH oxidases as therapeutic targets in ischemic stroke

   • Timo Kahles
   • Ralf P. Brandes

   Multi-author review 23 May 2012 Pages: 2345 - 2363

   

7. Targeting NOX enzymes in pulmonary fibrosis

   • Louise Hecker
   • Jeff Cheng
   • Victor J. Thannickal

   Multi-author review 23 May 2012 Pages: 2365 - 2371

   

8. NOX enzymes: potential target for the treatment of acute lung injury

   • Stéphanie Carnesecchi
   • Jean-Claude Pache
   • Constance Barazzone-Argiroffo

   Multi-author review 13 May 2012 Pages: 2373 - 2385

   

9. Targeting NOX enzymes in the central nervous system: therapeutic opportunities

   • Silvia Sorce
   • Karl-Heinz Krause
   • Vincent Jaquet

   Multi-author review 30 May 2012 Pages: 2387 - 2407

   

10. Targeting microglia-mediated neurotoxicity: the potential of NOX2 inhibitors

    • Michael J. Surace
    • Michelle L. Block

    Multi-author review 13 May 2012 Pages: 2409 - 2427

    

11. siRNA-mediated knock-down of NOX3: therapy for hearing loss?

    • Leonard P. Rybak
    • Debashree Mukherjea
    • Vickram Ramkumar

    Multi-author review 05 May 2012 Pages: 2429 - 2434

    

12. Targeting NADPH oxidases for the treatment of cancer and inflammation

    • Michael Y. Bonner
    • Jack L. Arbiser

    Multi-author review 13 May 2012 Pages: 2435 - 2442

    

13. The FAT10- and ubiquitin-dependent degradation machineries exhibit common and distinct requirements for MHC class I antigen presentation

    • Frédéric Ebstein
    • Andrea Lehmann
    • Peter-Michael Kloetzel

    Research Article Open access 19 February 2012 Pages: 2443 - 2454

    

14. Anion sensitivity and spectral tuning of middle- and long-wavelength-sensitive (MWS/LWS) visual pigments

    • Wayne I. L. Davies
    • Susan E. Wilkie
    • David M. Hunt

    Research Article 15 February 2012 Pages: 2455 - 2464